Atlas Trials

Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLC

Clinical trial NCT00517595 · COMPLETED

Trial details

NCT number
NCT00517595
Sponsor
Accelerated Community Oncology Research Network
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-Small Cell Lung Cancer
Start date
2007-08-01
Primary completion
2011-04-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.